{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:53:48Z","timestamp":1790376828372,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either <jats:italic>MYCN<\/jats:italic> (type 1) or <jats:italic>MIR17HG<\/jats:italic> that encodes miR-17-92 microRNAs (type 2). Since miR-17-92 expression is transcriptionally regulated by MYC transcription factors, it has been postulated that Feingold syndrome type 1 and 2 may be caused by a common molecular mechanism. Here we show that <jats:italic>Mir17-92<\/jats:italic> deficiency upregulates TGF-\u03b2 signaling, whereas <jats:italic>Mycn<\/jats:italic>-deficiency downregulates PI3K signaling in limb mesenchymal cells. Genetic or pharmacological inhibition of TGF-\u03b2 signaling efficiently rescues the skeletal defects caused by <jats:italic>Mir17-92<\/jats:italic> deficiency, suggesting that upregulation of TGF-\u03b2 signaling is responsible for the skeletal defect of Feingold syndrome type 2. By contrast, the skeletal phenotype of <jats:italic>Mycn<\/jats:italic>-deficiency is partially rescued by <jats:italic>Pten<\/jats:italic> heterozygosity, but not by TGF-\u03b2 inhibition. These results strongly suggest that despite the phenotypical similarity, distinct molecular mechanisms underlie the pathoetiology for Feingold syndrome type 1 and 2.<\/jats:p>","DOI":"10.1038\/s41467-018-03788-7","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T14:10:44Z","timestamp":1523455844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models"],"prefix":"10.1038","volume":"9","author":[{"given":"Fatemeh","family":"Mirzamohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyfallia","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Paltrinieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur M.","family":"Ayturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"3788_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajmg.a.20471","volume":"122A","author":"J Celli","year":"2003","unstructured":"Celli, J., van Bokhoven, H. & Brunner, H. G. Feingold syndrome: clinical review and genetic mapping. Am. J. Med. Genet. A 122A, 294\u2013300 (2003).","journal-title":"Am. J. Med. Genet. A"},{"key":"3788_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/ng.915","volume":"43","author":"L de Pontual","year":"2011","unstructured":"de Pontual, L. et al. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat. Genet. 43, 1026\u20131030 (2011).","journal-title":"Nat. Genet."},{"key":"3788_CR3","doi-asserted-by":"crossref","unstructured":"Ganjavi, H., Siu, V. M., Speevak, M. & MacDonald, P. A. A fourth case of Feingold syndrome type 2: psychiatric presentation and management. BMJ Case Rep. bcr2014207501(2014).","DOI":"10.1136\/bcr-2014-207501"},{"key":"3788_CR4","doi-asserted-by":"crossref","unstructured":"Ruiz-Perez, M. V., Henley, A. B. & Arsenian-Henriksson, M. The MYCN protein in health and disease. Genes (Basel) 8,E113 (2017).","DOI":"10.3390\/genes8040113"},{"key":"3788_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839\u2013843 (2005).","journal-title":"Nature"},{"key":"3788_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ccr.2014.06.014","volume":"26","author":"Y Li","year":"2014","unstructured":"Li, Y., Choi, P. S., Casey, S. C., Dill, D. L. & Felsher, D. W. MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer Cell. 26, 262\u2013272 (2014).","journal-title":"Cancer Cell."},{"key":"3788_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828\u2013833 (2005).","journal-title":"Nature"},{"key":"3788_CR8","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.biocel.2010.03.004","volume":"42","author":"V Olive","year":"2010","unstructured":"Olive, V., Jiang, I. & He, L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42, 1348\u20131354 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"3788_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405\u2013414 (2008).","journal-title":"Nat. Immunol."},{"key":"3788_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875\u2013886 (2008).","journal-title":"Cell"},{"key":"3788_CR11","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1101\/gad.1861409","volume":"23","author":"V Olive","year":"2009","unstructured":"Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839\u20132849 (2009).","journal-title":"Genes Dev."},{"key":"3788_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccr.2008.02.013","volume":"13","author":"F Petrocca","year":"2008","unstructured":"Petrocca, F. et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 13, 272\u2013286 (2008).","journal-title":"Cancer Cell."},{"key":"3788_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.molcel.2010.11.038","volume":"40","author":"P Mestdagh","year":"2010","unstructured":"Mestdagh, P. et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma. Mol. Cell 40, 762\u2013773 (2010).","journal-title":"Mol. Cell"},{"key":"3788_CR14","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1101\/gad.6.12a.2248","volume":"6","author":"J Charron","year":"1992","unstructured":"Charron, J. et al. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 6, 2248\u20132257 (1992).","journal-title":"Genes Dev."},{"key":"3788_CR15","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1242\/dev.000703","volume":"134","author":"S Ota","year":"2007","unstructured":"Ota, S., Zhou, Z. Q., Keene, D. R., Knoepfler, P. & Hurlin, P. J. Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development 134, 1583\u20131592 (2007).","journal-title":"Development"},{"key":"3788_CR16","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/ng1803","volume":"38","author":"E Hornstein","year":"2006","unstructured":"Hornstein, E. & Shomron, N. Canalization of development by microRNAs. Nat. Genet. 38, S20\u2013S24 (2006).","journal-title":"Nat. Genet."},{"key":"3788_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gde.2014.03.005","volume":"27","author":"DM Posadas","year":"2014","unstructured":"Posadas, D. M. & Carthew, R. W. MicroRNAs and their roles in developmental canalization. Curr. Opin. Genet. Dev. 27, 1\u20136 (2014).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"3788_CR18","first-page":"594738","volume":"2009","author":"N Shomron","year":"2009","unstructured":"Shomron, N., Golan, D. & Hornstein, E. An evolutionary perspective of animal microRNAs and their targets. J. Biomed. Biotechnol. 2009, 594738 (2009).","journal-title":"J. Biomed. Biotechnol."},{"key":"3788_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","volume":"18","author":"CP Concepcion","year":"2012","unstructured":"Concepcion, C. P., Bonetti, C. & Ventura, A. The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J. 18, 262\u2013267 (2012).","journal-title":"Cancer J."},{"key":"3788_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ng.3321","volume":"47","author":"YC Han","year":"2015","unstructured":"Han, Y. C. et al. An allelic series of miR-17 approximately 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat. Genet. 47, 766\u2013775 (2015).","journal-title":"Nat. Genet."},{"key":"3788_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-213X-10-69","volume":"10","author":"CI Lorda-Diez","year":"2010","unstructured":"Lorda-Diez, C. I., Montero, J. A., Garcia-Porrero, J. A. & Hurle, J. M. Tgfbeta2 and 3 are coexpressed with their extracellular regulator Ltbp1 in the early limb bud and modulate mesodermal outgrowth and BMP signaling in chicken embryos. BMC Dev. Biol. 10, 69 (2010).","journal-title":"BMC Dev. Biol."},{"key":"3788_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.orthres.2003.10.023","volume":"22","author":"CM Ferguson","year":"2004","unstructured":"Ferguson, C. M. et al. Transforming growth factor-beta1 induced alteration of skeletal morphogenesis in vivo. J. Orthop. Res. 22, 687\u2013696 (2004).","journal-title":"J. Orthop. Res."},{"key":"3788_CR23","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1128\/MCB.20.14.5010-5018.2000","volume":"20","author":"F Vazquez","year":"2000","unstructured":"Vazquez, F., Ramaswamy, S., Nakamura, N. & Sellers, W. R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell. Biol. 20, 5010\u20135018 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"3788_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2006.02.024","volume":"374","author":"A Gericke","year":"2006","unstructured":"Gericke, A., Munson, M. & Ross, A. H. Regulation of the PTEN phosphatase. Gene 374, 1\u20139 (2006).","journal-title":"Gene"},{"key":"3788_CR25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1074\/jbc.M009134200","volume":"276","author":"J Torres","year":"2001","unstructured":"Torres, J. & Pulido, R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993\u2013998 (2001).","journal-title":"J. Biol. Chem."},{"key":"3788_CR26","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1172\/JCI34616","volume":"118","author":"A Silva","year":"2008","unstructured":"Silva, A. et al. PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability. J. Clin. Invest. 118, 3762\u20133774 (2008).","journal-title":"J. Clin. Invest."},{"key":"3788_CR27","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1038\/sj.onc.1205640","volume":"21","author":"P Channavajhala","year":"2002","unstructured":"Channavajhala, P. & Seldin, D. C. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene 21, 5280\u20135288 (2002).","journal-title":"Oncogene"},{"key":"3788_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0167-4889(95)00100-7","volume":"1269","author":"DW Litchfield","year":"1995","unstructured":"Litchfield, D. W., Bosc, D. G. & Slominski, E. The protein kinase from mitotic human cells that phosphorylates Ser-209 on the casein kinase II beta-subunit is p34cdc2. Biochim. Biophys. Acta 1269, 69\u201378 (1995).","journal-title":"Biochim. Biophys. Acta"},{"key":"3788_CR29","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"Mogilyansky, E. & Rigoutsos, I. The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 20, 1603\u20131614 (2013).","journal-title":"Cell Death Differ."},{"key":"3788_CR30","doi-asserted-by":"crossref","unstructured":"Kalkat, M. et al. MYC deregulation in primary human cancers. Genes (Basel) 8, E151 (2017).","DOI":"10.3390\/genes8060151"},{"key":"3788_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/gene.10092","volume":"33","author":"M Logan","year":"2002","unstructured":"Logan, M. et al. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33, 77\u201380 (2002).","journal-title":"Genesis"},{"key":"3788_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C","volume":"26","author":"DA Ovchinnikov","year":"2000","unstructured":"Ovchinnikov, D. A., Deng, J. M., Ogunrinu, G. & Behringer, R. R. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 26, 145\u2013146 (2000).","journal-title":"Genesis"},{"key":"3788_CR33","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1101\/gad.1021202","volume":"16","author":"PS Knoepfler","year":"2002","unstructured":"Knoepfler, P. S., Cheng, P. F. & Eisenman, R. N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699\u20132712 (2002).","journal-title":"Genes Dev."},{"key":"3788_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/tera.1420220306","volume":"22","author":"MJ McLeod","year":"1980","unstructured":"McLeod, M. J. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22, 299\u2013301 (1980).","journal-title":"Teratology"},{"key":"3788_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0012-1606(66)90048-0","volume":"13","author":"R Umansky","year":"1966","unstructured":"Umansky, R. The effect of cell population density on the developmental fate of reaggregating mouse limb bud mesenchyme. Dev. Biol. 13, 31\u201356 (1966).","journal-title":"Dev. Biol."},{"key":"3788_CR36","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1242\/dev.121.12.4237","volume":"121","author":"AG Haramis","year":"1995","unstructured":"Haramis, A. G., Brown, J. M. & Zeller, R. The limb deformity mutation disrupts the SHH\/FGF-4 feedback loop and regulation of 5\u2019 HoxD genes during limb pattern formation. Development 121, 4237\u20134245 (1995).","journal-title":"Development"},{"key":"3788_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F","volume":"209","author":"Q Zhao","year":"1997","unstructured":"Zhao, Q., Eberspaecher, H., Lefebvre, V. & De Crombrugghe, B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209, 377\u2013386 (1997).","journal-title":"Dev. Dyn."},{"key":"3788_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4939-6524-3_9","volume":"1509","author":"S Quinlan","year":"2017","unstructured":"Quinlan, S., Henke, C., Brennan, G. P., Henshall, D. C. & Jimenez-Mateos, E. M. Detection of microRNAs in brain slices using in situ hybridization. Methods Mol. Biol. 1509, 85\u201391 (2017).","journal-title":"Methods Mol. Biol."},{"key":"3788_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03788-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:38:14Z","timestamp":1671543494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03788-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["3788"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-03788-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"10 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1352"}}